Nodular glomerulosclerosis in a non-diabetic hypertensive smoker with dyslipidemia
Palabras clave:
Nodular glomerulosclerosis. Smoking. Hypertension.Resumen
Nodular glomerulosclerosis may be idiopathic or develop associated with diabetes mellitus, membranoprolipherative glomerulonephritis, light or heavy chain deposits, amyloidosis, fibrillary or immunotactoide disease, and Takayasu’s arteritis. Histological features of idiopathic nodular glomerulosclerosis are similar to the Kimmelstiel-Wilson changes. Recent evidence points to the role of hyperglycemia, hyperlipidemia, hypertension and smoking in the mechanisms of this uncommon condition. The case study of a 65-year-old male presenting recent arterial hypertension and nodular non-diabetic glomerulosclerosis is described, and the possible role of heavy smoking in the pathogenesis of this condition is emphasized.Descargas
Citas
1. KIKUTA T, INOUE T, WATANABE Y, SATO T, TSUDAI M, UCHIDA K et al. [Association between long-term smoking and hypertension and early-onset nodular glomerulosclerosis]. Nippon Jinzo Gakkai Shi 2010; 52: 959-965.
2. KUPPACHI S, IDRIS N, CHANDER PN, YOO J. Idiopathic nodular glomeurulosclerosis in a non-diabetic hypertensive smoker-case report and review of literature. Neprhol Dial Transplant 2006; 21: 3571-3575.
https://doi.org/10.1093/ndt/gfl422
3. LI W, VERANI RR. Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases. Hum Pathol 2008; 39: 1771-1776.
https://doi.org/10.1016/j.humpath.2008.05.004
4. MARKOWITZ GS, LIN J, VALERI AM, AVILA C, NASR SH, D'AGATI VD. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol 2002; 33: 826-835.
https://doi.org/10.1053/hupa.2002.126189
5. NASR SH, D'AGATI VD. Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol 2007; 18: 2032-2036.
https://doi.org/10.1681/ASN.2006121328
6. HERNÁNDEZ-GARCÍA I, SÁENZ-GONZÁLEZ MC, GONZÁLEZ-CELADORR. Mortalidad atribuible al consumo de tabaco en España en el año 2006. An Sist Sanit Navar 2010; 33: 23-33.
https://doi.org/10.4321/S1137-66272010000100003
7. VELASQUEZ MT, ABRAHAM AA, KIMMEL PL, FARKAS-SZALLASI T, MICHAELIS OE 4TH. Diabetic glomerulopathy in the SHR/N-corpulent rat: role of dietary carbohydrate in a model of NIDDM. Diabetologia 1995; 38: 31-38.
https://doi.org/10.1007/BF02369350
8. HUA P, FENG W, JI S, RAIJ L, JAIMES EA. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol 2010; 299: F732-39.
https://doi.org/10.1152/ajprenal.00293.2010
9. YAMAMOTO K, OKAZAKI A, OHMORI S. The relationship between psychosocial stress, age, BMI, CRP, lifestyle, and the metabolic syndrome in apparently healthy subjects. J Physiol Anthropol 2011; 30: 15-22.
https://doi.org/10.2114/jpa2.30.15
10. BUSARI OA, OPADIJO OG, OLAREWAJU OT. Microalbuminuria and its relations with serum lipid abnormalities in adult Nigerians with newly diagnosed hypertension. Ann Afr Med 2010; 9: 62-67.
https://doi.org/10.4103/1596-3519.64750
11. FÉLIX-REDONDO FJ, FERNÁNDEZ-BERGÉS D, PÉREZ DF, ZARO MJ, GARCÍA A, LOZANO L et al. Prevalencia, detección, tratamiento y grado de control de los factores de riesgo cardiovascular en la población de Extremadura (España). Estudio HERMEX. Aten Primaria 2011. doi:10.1016/j.aprim.2010.07.008:
https://doi.org/10.1016/j.aprim.2010.07.008
12. OLIVEIRA HF, MARTINS LC, REATO LFN, AKERMAN M. Fatores de risco para uso do tabaco em adolescentes de duas escolas do município de Santo André, São Paulo. Rev Paul Pediatr 2010; 28: 200-207.
https://doi.org/10.1590/S0103-05822010000200012
13. SANTOS VM. Aspectos da indústria do tabaco no Brasil. J Bras Pneumol 1979; 5: 149-152.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2011 Anales del Sistema Sanitario de Navarra
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
